Some Senate Republicans emerged disappointed from a closed-door briefing Tuesday with FDA Commissioner Marty Makary, saying the agency is not taking a safety review of the abortion pill mifepristone seriously and calling for congressional action to curb access to the drug.
Sen. Josh Hawley (R-Mo.) said in an interview Makary failed to give a timeline for completion of the review, explain what the audit will involve and disclose whether it was even underway.
“I think that this safety study is a dead end,” Hawley said. “I just think that FDA is not serious about it. I don’t think that they’re proceeding with any sense of urgency whatsoever. If…
Read the full article at POLITICO.COM
